Seroprevalence of Herpes Simplex Virus Types 1 and 2 among Pregnant Women in South-Western Romania

• Published in: Life (Basel, Switzerland) Vol. 14; no. 5; p. 596
• Main Authors: Radoi, Cristiana Luiza, Cristea, Oana Mariana, Vulcanescu, Dan Dumitru, Voinescu, Adela, Dragomir, Tiberiu Liviu, Sima, Laurentiu Vasile, Tanasescu, Sonia, Harich, Octavia Oana, Balasoiu, Andrei Theodor, Iliescu, Dominic Gabriel, Zlatian, Ovidiu
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.05.2024
• Subjects: Age groups; Antibodies; Disease control; Distribution; Emergency medical services; Epidemiology; Fetuses; Health aspects; herpes; Herpes simplex; Herpes simplex virus; Herpes viruses; Immunoglobulin G; Infections; Laboratories; Pregnancy; Pregnant women; Romania; Rural areas; Serology; seroprevalence; Software; Urban areas; Womens health; Romania; Northern Europe; Asia; United States > US; Eastern Europe; Europe; Southern Europe; Australia; Western Europe; Latin America; seroprevalence; Romania; herpes; pregnancy
• ISSN: 2075-1729; 2075-1729
• DOI: 10.3390/life14050596

Pregnancy-related infections with the human herpes simplex virus (HSV) strains HSV-1 and HSV-2 are particularly noteworthy. There are numerous reported examples of intrapartum transmission of herpes infection, notwithstanding the extreme rarity of intrauterine transfer from mother to fetus. The purpose of this study was to evaluate the seroprevalence of HSV-1 and HSV-2 antibodies in pregnant women in the western region of Romania. Pregnant women who presented for routine pregnancy monitoring at Romania's County Clinical Emergency Hospital in Craiova between 2013 and 2016 and 2019 and 2022 were included in the study. In order to find anti-HSV-1/2 IgG antibodies, we conducted serological testing on the patients and gathered demographic information from them. HSV-1 seroprevalence was shown to have declined in rural areas and increased in urban areas, with values between 2013 and 2016 being 89.30% and those between 2019 and 2022 being 84.96%, respectively. Women over 35 who were pregnant had the highest seroprevalence. The seroprevalence of HSV-2 decreased from 16.16% in 2013-2016 to 12.43% in 2019-2022, and both rural and urban areas continued to experience this declining trend. Similarly, pregnant women over 35 years old had the highest frequency of HSV-1 infections. Establishing educational programs and other actions to reduce the transmission rate and ultimately the prevalence of the disease can be made easier with knowledge about the seroprevalence of HSV-1 and HSV-2 infections.